Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Shirsath Nitesh Pralhad |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2019
Originalarbeit (Zeitschrift)
** Prutsch, N; Gurnhofer, E; Suske, T; Liang, HC; Schlederer, M; Roos, S; Wu, LC; Simonitsch-Klupp, I; Alvarez-Hernandez, A; Kornauth, C; Leone, DA; Svinka, J; Eferl, R; Limberger, T; Aufinger, A; Shirsath, N; Wolf, P; Hielscher, T; Aberger, F; Schmoellerl, J; Stoiber, D; Strobl, B; Jäger, U; Staber, PB; Grebien, F; Moriggl, R; Müller, M; Inghirami, GG; Sanda, T; Look, AT; Turner, SD; Kenner, L; Merkel, O
Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma.
Leukemia. 2019; 33(3):696-709
Doi: 10.1038/s41375-018-0239-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2018
Originalarbeit (Zeitschrift)
** Shirsath, N; Wagner, K; Tangermann, S; Schlederer, M; Ringel, C; Kenner, L; Brüne, B; Wolf, P
8-Methoxypsoralen Plus Ultraviolet A Reduces the Psoriatic Response to Imiquimod in a Murine Model.
ACTA DERM-VENEREOL. 2018; 98(6): 576-584.
Doi: 10.2340/00015555-2905
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Originalarbeit (Zeitschrift)
** Buerger, C; Shirsath, N; Lang, V; Berard, A; Diehl, S; Kaufmann, R; Boehncke, WH; Wolf, P
Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation.
PLoS One. 2017; 12(7):e0180853-e0180853
Doi: 10.1371/journal.pone.0180853
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bürger, C; Shirsath, N; Lang, V; Diehl, S; Kaufmann, R; Weigert, A; Han, YY; Ringel, C; Wolf, P
Blocking mTOR Signalling with Rapamycin Ameliorates Imiquimod-induced Psoriasis in Mice.
Acta Derm Venereol. 2017; 97(9):1087-1094
Doi: 10.2340/00015555-2724
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Shirsath, N; Lang, V; Diehl, S; Weigert, A; Han, Y; Kaufmann, R; Wolf, P; Buerger, C
Topical rapamycin ameliorates imiquimod induced psoriasis-like skin inflammation in mice
EXP DERMATOL. . 2017; 26(3):E21-E22.-44th Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF); MAR 09-11, 2017; Gottingen, GERMANY.
[Poster]
Web of Science
** Shirsath, N; Wagner, K; Ober, J; Mayer, G; Schlederer, M; Roos, S; Kenner, L; Wolf, P
PUVA diminishes imiquimod-induced psoriatic phenotype with gene expression signature associated with senescence
J INVEST DERMATOL. 2017; 137(10):S301-S301.-47th Annual Meeting of the European-Society-for-Dermatological-Research (ESDR); SEP 27-30, 2017; Salzburg, AUSTRIA.
Doi: 10.1016/j.jid.2017.07.311
[Poster]
Web of Science
FullText
FullText_MUG
2016
Originalarbeit (Zeitschrift)
** Schweintzger, NA; Gruber-Wackernagel, A; Shirsath, N; Quehenberger, F; Obermayer-Pietsch, B; Wolf, P
Influence of the season on vitamin D levels and regulatory T cells in patients with polymorphic light eruption.
Photochem Photobiol Sci. 2016; 15(3):440-446
Doi: 10.1039/c5pp00398a
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Shirsath, N; Lang, V; Diehl, S; Kaufmann, R; Wolf, P; Buerger, C
Blocking mTOR signaling with rapamycin ameliorates imiquimod-induced psoriasis in mice
J INVEST DERMATOL. 2016; 136(9):S221-S221.-Annual Meeting of the European-Society-for-Dermatological-Research (ESDR); SEP 07-10, 2016; Munich, GERMANY.
Doi: 10.1016/j.jid.2016.06.377
[Poster]
Web of Science
FullText
FullText_MUG
** Shirsath, N; Mayer, G; Frei, R; Ober, J; Heinemann, A; Wolf, P
PUVA pretreatment leads to reduced induction of inflammation in the imiquimod model of psoriasis
EXP DERMATOL. 2016; 25(3):E33-E33.-43rd Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung-e-V (ADF); MAR 10-12, 2016; Vienna, AUSTRIA.
[Poster]
Web of Science
2015
Kurzbericht/Letter
** Shirsath, N; Mayer, G; Singh, TP; Wolf, P
8-methoxypsoralen plus UVA (PUVA) therapy normalizes signalling of phosphorylated component of mTOR pathway in psoriatic skin of K5.hTGF beta 1 transgenic mice
EXP DERMATOL. 2015; 24(11): 889-891.
Doi: 10.1111/exd.12779
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Shirsath, N; Mayer, G; Ober, J; Schweintzger, N; Wolf, P
PUVA leads to reduced inflammation in the imiquimod model of psoriasis
J INVEST DERMATOL. 45th Annual Meeting of the European-Society-for-Dermatological-Research. 2015; 135: S78-S78.-45th Annual Meeting of the European-Society-for-Dermatological-Research; SEP 09-12, 2015; Rotterdam, NETHERLANDS.
Web of Science
2014
Originalarbeit (Zeitschrift)
** Joshi, N; Shirsath, N; Singh, A; Joshi, KS; Banerjee, R
Endogenous lung surfactant inspired pH responsive nanovesicle aerosols: pulmonary compatible and site-specific drug delivery in lung metastases.
Sci Rep. 2014; 4:7085-7085
Doi: 10.1038/srep07085
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Shirsath, NP; Mayer, G; Singh, TP; Wolf, P
Activation of mammalian target of rapamycin and its downstream signaling components in psoriatic skin and its downregulation by 8-methoxypsoralen plus ultraviolet A therapy
J INVEST DERMATOL. 2014; 134: S84-S84.-44th Annual Meeting of the European-Society-for-Dermatological-Research (ESDR); SEP 10-13, 2014; Copenhagen, DENMARK.
[Oral Communication]
Web of Science
2013
Originalarbeit (Zeitschrift)
** Shirsath, N; Rathos, M; Chaudhari, U; Sivaramakrishnan, H; Joshi, K
Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
Lung Cancer. 2013; 82(2):214-221
Doi: 10.1016/j.lungcan.2013.08.010
Web of Science
PubMed
FullText
FullText_MUG
2012
Originalarbeit (Zeitschrift)
** Shirsath, NP; Manohar, SM; Joshi, KS
P276-00, a cyclin-dependent kinase inhibitor, modulates cell cycle and induces apoptosis in vitro and in vivo in mantle cell lymphoma cell lines.
Mol Cancer. 2012; 11:77-77
Doi: 10.1186/1476-4598-11-77
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG